[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3813 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 3813
To accelerate the applicability of the requirement that the Director of
the Centers for Disease Control and Prevention be appointed by the
President, by and with the consent of the Senate.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 5, 2023
Mr. Guthrie introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To accelerate the applicability of the requirement that the Director of
the Centers for Disease Control and Prevention be appointed by the
President, by and with the consent of the Senate.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``CDC Leadership Accountability Act of
2023''.
SEC. 2. ACCELERATING APPLICABILITY OF REQUIREMENT THAT CDC DIRECTOR BE
CONFIRMED BY SENATE.
Subsection (b) of section 2101 of division FF of the Consolidated
Appropriations Act, 2023 (Public Law 117-328) is amended to read as
follows:
``(b) Applicability.--
``(1) In general.--The first sentence of section 305(a) of
the Public Health Service Act, as added by subsection (a),
applies with respect to any Director of the Centers for Disease
Control and Prevention appointed on or after June 1, 2023.
``(2) Special rule.--Any individual appointed during the
period beginning on June 1, 2023, and ending on the date of
enactment of this Act to serve as the Director of the Centers
for Disease Control and Prevention is deemed to be serving in
an acting capacity until the requirements of the first sentence
of section 305(a) of the Public Health Service Act, as added by
subsection (a), are met.''.
<all>